Wockhardt claims FDA issues with U.S. plant have been resolved

Wockhardt Chairman Habil Khorakiwala claims the company has satisfied FDA concerns laid out in a Form 483 by inspectors last year for a plant in Morton Grove, IL. The plant is key for Wockhardt after the FDA in 2013 banned two of its Indian plants for quality and data manipulation issues. Khorakiwala made the announcement while discussing the company's earnings. Story | More